AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

Find Radio Compass News for Ensartinib

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://www.businesswire.com/news/home/20240313675039/en

BUSINESSWIRE
13 Mar 2024

https://www.businesswire.com/news/home/20220322006197/en

BUSINESSWIRE
22 Mar 2022

https://www.fiercepharma.com/marketing/takeda-value-based-drug-pricing-lung-cancer-alunbrig-pfizer-xalkori-discount-rebate

Angus Liu FIERCEPHARMA
09 Nov 2021

https://www.businesswire.com/news/home/20191029005146/en/Vanderbilt-Oncologists-Publish-Results-Study-Demonstrate-Clinical

BUSINESSWIRE
29 Oct 2019

https://www.biospace.com/article/releases/the-lancet-respiratory-medicine-published-study-shows-ensartinib-holds-promise-as-a-new-treatment-option-for-alk-positive-non-small-cell-lung-cancer-nsclc-/?s=95

BIOSPACE
18 Oct 2019

https://www.businesswire.com/news/home/20191017006005/en

BUSINESSWIRE
17 Oct 2019

http://abcnews.go.com/Health/wireStory/publix-reverses-cover-hiv-prevention-drug-workers-52880515

ABCNEWS
07 Feb 2018
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY